7th Berlin Conference on IP in Life Sciences: Big Data - Big Drugs
The health care industry faces significant transformation, driven by a boom in knowledge within biomedical sciences and breakthrough technologies such as gene sequencing. The advances in information technology are turning this evolution into a revolution. The management of "big data“ will change the understanding of diseases, development of drugs and treatment of patients.
Biotech and pharma companies who adopt big data technologies hope for large rewards - but how will intellectual property (IP) be impacted by the use of big data? This BIOCOM Event offers a unique opportunity to gain an insight into the strategies of life sciences and IT companies concerning new data-driven concepts and the patenting issues and opportunities that arise.
Date: 07 February 2013
Location: Berlin, Germany